Product
Supplier
Encyclopedia
Inquiry
99% High Purity FOX04-DRI buy - large image1
99% High Purity FOX04-DRI buy - image1
99% High Purity FOX04-DRI buy - image2
99% High Purity FOX04-DRI buy - image3
99% High Purity FOX04-DRI buy - image4
99% High Purity FOX04-DRI buy - image5
99% High Purity FOX04-DRI buy - image6

99% High Purity FOX04-DRI

30 Inquiries

Unit Price:

$95-100/UNIT FOB

Get Latest Price
CAS No.:

2460055-10-9

Grade:

Pharmaceutical Grade

Content:

99%

Port:

深圳

Packaging:

10mg/vial, 10vials/box

Price valid (until):

2028-07-09

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents
Average Lead Time:
1 days
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    1. Ultra-High Purity
    Each batch is synthesized and purified to >99% purity (HPLC), ensuring reliable and reproducible results in sensitive experiments.


    2.Accurate Dosing & Consistency
    Our peptides are precisely weighed and vacuum-sealed under sterile conditions. Batch-to-batch consistency is rigorously maintained.


    3.Endotoxin-Free & Sterile Processing
    Manufactured in a cleanroom environment, our peptides are free from endotoxins, microbial contamination, and other impurities that could interfere with cell-based or in vivo studies.


    Shop Cortagen 20mg-Detailed Image 1


    Shop Cagrilintide 2mg 5mg 10mg-Detailed Image 2

    Shop Cagrilintide 2mg 5mg 10mg-Detailed Image 3
    Shop Cortagen 20mg-Detailed Image 4
    Shop 99% High Purity FOX04-DRI-Detailed Image 5
    Shop 99% High Purity FOX04-DRI-Detailed Image 6

    Shop Cagrilintide 2mg 5mg 10mg-Detailed Image 5

    Items Specifications
    vial mg
    tude g
    bag kg
    ECHEMI Editorial Reference
    FOXO4-DRI (Retro-Inverso) is a synthetic, slightly modified version of the standard FOXO4 protein. The modification prolongs half-life of the protein and allows it to interfere with normal FOXO4 function. FOXO4-DRI has been shown in research to prevent normal FOXO4 binding to p53, thereby allowing for elimination of senescent cells, improved organ function, and younger tissue “biological age.” FOXO4-DRI impacts insulin signaling, cell cycle regulation, and oxidative stress signaling pathways. FOXO4-DRI is a cell penetrating peptide shown to selectively induce apoptosis of senescent cells thereby reversing effects of aging in animal studies.
    Research & Reference Note

    99% High Purity FOX04-DRI is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Disclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals

    Basic Info
    Product Name:

    FOXO4-DRI

    Other Name:

    FOXO4-DRI;FOXO4 /FOXO4-DRI;FOX04-DRI (D-Retro-Inverso);Fox4-dri

    CAS No.:

    2460055-10-9

    Molecular Weight:

    0

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide

    Location:

    Unit 1207, Elevator 1, Office Tower A2, Wanda Plaza, No. 8 Aojiang Road, Taijiang District, Fuzhou City, Fujian Province

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    1 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    5-10

    Year of Establishment:

    2024

  • Inquiry History
    30 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    FOXO4-DRI

    1 G Dec 3, 2023
    Germany

    foxo4-dri

    1 G Aug 23, 2026
    United States

    Fox04-dri

    1 G May 20, 2026
    United States

    hot-sale-high-purity-raw-powder-fox04-dri-nad-ghk-cu-mot

    2 PCS Dec 19, 2025
    United States

    foxo4 dri

    10 MT Dec 13, 2025
    United States

    Fox04

    10 MG Oct 30, 2024
    United States

    Fox04 dri

    10 MT Jun 21, 2026
    United States

    FOX04-DRI powder

    10 MT May 29, 2026
    United States

    fox04

    1 G Apr 29, 2026
    United States

    FOXO4-DRI

    1 KG Mar 23, 2026
    United States

    Foxo4-Dri

    2  Nov 24, 2025
    United States

    FOXO4

    10 PCS Nov 15, 2025
    United States

    Fox04

    1 G Nov 10, 2025
    United States

    FOX04

    10 G Oct 22, 2025
    United States

    FOXO4-DRI

    5 PCS Oct 18, 2025
    Russia

    Foxo4dri

    5 G Sep 11, 2025
    United States

    FOX04-DRI

    100 MG Aug 1, 2025
    Canada

    Reta

    10 PCS Sep 24, 2026
    Germany

    FOXO4-DRI

    10 MG Sep 17, 2026
    Norway

    FOXO4-DRI

    200 MG Sep 3, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.